Due to a national shortage of blood collection tubes, you may experience upwards of a 2-hour delay in processing time for certain tests. Someone from our team will advise you if your scheduled lab test is affected by this delay. We thank you in advance for your patience.
Make First Appointment Refer a Patient

Clinical Trials & Research

Home / Clinical Trials & Research / View Open Trials / 20297 - Ph1/2 BDC-1001 +/- Pembro HER2 Solids

20297 - Ph1/2 BDC-1001 +/- Pembro HER2 Solids

Phase 1/2 Study of BDC-1001 as a Single Agent and in Combination with Pembrolizumab in Patients with Advanced HER2-Expressing Solid Tumors (BBI-20201001)

Disease Types: Solid Tumors,&nbs

Available at: {clinical_trial_location backspace="7"} 20297 - Ph1/2 BDC-1001 +/- Pembro HER2 Solids, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}